Viewing Study NCT03321695


Ignite Creation Date: 2025-12-24 @ 2:19 PM
Ignite Modification Date: 2026-01-04 @ 5:31 AM
Study NCT ID: NCT03321695
Status: COMPLETED
Last Update Posted: 2023-03-13
First Post: 2017-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-12-27
Start Date Type: ACTUAL
Primary Completion Date: 2019-03-02
Primary Completion Date Type: ACTUAL
Completion Date: 2019-03-02
Completion Date Type: ACTUAL
First Submit Date: 2017-10-20
First Submit QC Date: None
Study First Post Date: 2017-10-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-09
Last Update Post Date: 2023-03-13
Last Update Post Date Type: ACTUAL